
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| MORPHINE SULFATE | Fresenius Kabi | N-204223 RX | 2013-10-30 | 3 products, RLD, RS |
| DURAMORPH PF | Hikma Pharmaceuticals | N-018565 RX | 1984-09-18 | 2 products, RLD, RS |
| INFUMORPH | Hikma Pharmaceuticals | N-018565 RX | 1991-07-19 | 2 products, RLD, RS |
| MORPHINE SULFATE | Hikma Pharmaceuticals | N-022195 RX | 2008-03-17 | 3 products, RLD |
| MORPHINE SULFATE | Hikma Pharmaceuticals | N-022207 RX | 2008-03-17 | 2 products, RLD, RS |
| MORPHINE SULFATE | Hospira | N-202515 RX | 2011-11-14 | 5 products, RLD |
| MS CONTIN | Purdue Pharma | N-019516 RX | 1987-05-29 | 5 products, RLD |
Brand Name | Status | Last Update |
|---|---|---|
| avinza | New Drug Application | 2011-09-22 |
| depodur | 2008-01-10 | |
| duramorph | New Drug Application | 2024-04-09 |
| embeda | New Drug Application | 2010-01-22 |
| infumorph 200 infumorph 500 | New Drug Application | 2024-04-10 |
| kadian | New Drug Application | 2011-06-15 |
| mitigo | ANDA | 2025-09-23 |
| morphine sulfate | New Drug Application | 2025-09-19 |
| morphine sulfate extended-release | 2007-09-27 | |
| morphine sulfate morphine sulfate | New Drug Application | 2024-10-15 |
Expiration | Code | ||
|---|---|---|---|
MORPHINE SULFATE, MORPHINE SULFATE, HIKMA | |||
| 2024-06-02 | NPP | ||
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Morphine Sulfate, Morphine Sulfate, Fresenius Kabi Usa | |||
| 9072781 | 2034-03-12 | DP | |
| 9192608 | 2034-03-12 | U-43, U-55 | |
| 9248229 | 2034-03-12 | DP | |
| Morphine Sulfate, Arymo Er, Zyla | |||
| 9044402 | 2033-07-01 | DP | U-1556 |
| 9549899 | 2033-07-01 | DP | U-1556 |
| Morphine Sulfate / Naltrexone Hydrochloride, Embeda, Alpharma Pharms | |||
| 8623418 | 2029-11-07 | U-1640 | |
| 7815934 | 2027-12-12 | DP | |
| 7682633 | 2027-06-19 | U-1510 | |
| 7682634 | 2027-06-19 | DP | |
| 8158156 | 2027-06-19 | U-1510 | |
| 8846104 | 2027-06-19 | DP | |
| 8877247 | 2027-06-19 | DP | |
| 8685443 | 2025-07-03 | U-1508 | |
| 8685444 | 2025-07-03 | DP | |
| Morphine Sulfate, Morphabond Er, Ohemo Life | |||
| 7955619 | 2028-08-12 | DP | |
| 10314788 | 2028-08-12 | DP | |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pain | D010146 | EFO_0003843 | R52 | 1 | — | 1 | — | — | 2 |
| Neoplasms | D009369 | — | C80 | — | — | 1 | — | — | 1 |
| Chronic pain | D059350 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Diabetic neuropathies | D003929 | EFO_1000783 | — | — | 1 | — | — | — | 1 |
| Polyneuropathies | D011115 | EFO_0009562 | A69.22 | — | 1 | — | — | — | 1 |
| Postoperative pain | D010149 | — | G89.18 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | — | 1 |
| Hypercapnia | D006935 | — | — | 1 | — | — | — | — | 1 |
| Drug common name | Morphine |
| INN | — |
| Description | Morphine is a morphinane alkaloid that is a highly potent opiate analgesic psychoactive drug. Morphine acts directly on the central nervous system (CNS) to relieve pain but has a high potential for addiction, with tolerance and both physical and psychological dependence developing rapidly. Morphine is the most abundant opiate found in Papaver somniferum (the opium poppy). It has a role as an opioid analgesic, a mu-opioid receptor agonist, a plant metabolite, an environmental contaminant, a xenobiotic, a vasodilator agent, an anaesthetic, a drug allergen and a geroprotector. It is an organic heteropentacyclic compound, a tertiary amino compound and a morphinane alkaloid. It is a conjugate base of a morphine(1+). It derives from a hydride of a morphinan. |
| Classification | Small molecule |
| Drug class | Opioid |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 |













